Nombre de documents

14

CV de Puvirajesinghe Puvirajesinghe


Article dans une revue13 documents

  • Ronald Aznavourian, Tania Puvirajesinghe, S Brûlé, S Enoch, S Guenneau. Bio-inspired seismic metamaterials: Time domain simulations in transformed crystals. Journal of Physics: Condensed Matter, IOP Publishing, 2017. <hal-01395843>
  • Tania Puvirajesinghe, Jean-Paul Borg. Neural Tube Defects: From a Proteomic Standpoint. Metabolites, MDPI, 2015, 5 (1), pp.164-183. <10.3390/metabo5010164>. <hal-01451380>
  • Ina Kalus, Susanne Rohn, Tania Puvirajesinghe, Scott Guimond, Pieter Eyckerman-Kölln, et al.. Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions. PLoS ONE, Public Library of Science, 2015, 10 (10), pp.e0139853. <10.1371/journal.pone.0139853>. <hal-01451385>
  • Sebastien Guenneau, D Petiteau, Myriam Zerrad, Claude Amra, Tania Puvirajesinghe. Transformed Fourier and Fick equations for the control of heat and mass diffusion. AIP Advances, American Institute of Physics- AIP Publishing LLC, 2015, 5, pp.53404 - 400. <10.1063/1.4917492>. <hal-01451386>
  • Sebastien Guenneau, Tania Puvirajesinghe. Fick's second law transformed: one path to cloaking in mass diffusion. Interface, Royal Society, The, 2013, 10 (83), pp.20130106. <10.1098/rsif.2013.0106 >. <hal-01451387>
  • Tania Puvirajesinghe, Latifa Elantak, Sabrina Lignon, Nathalie Franche, Marianne Ilbert, et al.. DnaJ (Hsp40 Protein) Binding to Folded Substrate Impacts KplE1 Prophage Excision Efficiency. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2012, 287 (17), pp.14169-14177. <10.1074/jbc.M111.331462>. <hal-01447752>
  • Tania Puvirajesinghe, Yassir Ahmed, Andrew Powell, David Fernig, Scott Guimond, et al.. Array-Based Functional Screening of Heparin Glycans. Chemistry and Biology, Elsevier, 2012, 19 (5), pp.553-558. <10.1016/j.chembiol.2012.03.011>. <hal-01447680>
  • Tania Puvirajesinghe, Jeremy Turnbull. Glycomics Approaches for the Bioassay and Structural Analysis of Heparin/Heparan Sulphates. Metabolites, 2012, 2 (4), pp.1060-1089. <10.3390/metabo2041060>. <hal-01451376>
  • Stéphanie Champ, Tania Puvirajesinghe, Elsa Perrody, Rachid Menouni, Pierre Genevaux, et al.. Chaperone-assisted Excisive Recombination, a Solitary Role for DnaJ (Hsp40) Chaperone in Lysogeny Escape. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 286 (45), pp.38876-38885. <10.1074/jbc.M111.281865>. <hal-01447766>
  • S. Champ, T. Puvirajesinghe, E. Perrody, R. Menouni, P. Genevaux, et al.. Chaperone-assisted excisive recombination: a solitary role for DnaJ (Hsp40) in lysogeny escape. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 11 (286), pp.38876-85. <hal-00666940>
  • Jeremy Turnbull, Rebecca Miller, Yassir Ahmed, Tania Puvirajesinghe, Scott Guimond. Glycomics Profiling of Heparan Sulfate Structure and Activity. Methods in Enzymology, Elsevier, 2010, 480, pp.65-85. <10.1016/S0076-6879(10)80004-7>. <hal-01447774>
  • Scott Guimond, Tania Puvirajesinghe, Mark Skidmore, Ina Kalus, Thomas Dierks, et al.. Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and Tissues: TOWARD GLYCOMICS PROFILING. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2009, 284 (38), pp.25714-25722. <10.1074/jbc.M109.032755>. <hal-01447772>
  • Tania Puvirajesinghe, Scott Guimond, Jeremy Tunrbull, Sébastien Guenneau. Chemometric analysis for comparison of heparan sulphate oligosaccharides. Journal of the Royal Society Interface, Royal Society, 2009, 6, pp.997-1004. <10.1098/rsif.2008.0483>. <hal-00438879>

Brevet1 document

  • Tania Puvirajesinghe, Zhi Lane, Richard Craster, Sébastien Guenneau. A 3-dimensional spherical cloak for prolonged delayed diffusion of a therapeutic peptide drug and a small chemical compound used as anti-cancer agents. Antibody structures provide targeted therapy. France, Patent n° : EP16305485.1. 2016. <hal-01332176>